Novel Therapies in Ovarian Cancer Management: An Update on the Role of Topotecan

Deborah K. Armstrong
The Oncologist 2002; 7(Supplement 5 ): 1-2; doi:10.1634/theoncologist.7-suppl_5-1
[Full Text] [PDF]  

Update on the Role of Topotecan in the Treatment of Recurrent Ovarian Cancer

Thomas J. Herzog
The Oncologist 2002; 7(Supplement 5 ): 3-10; doi:10.1634/theoncologist.7-suppl_5-3
[Abstract] [Full Text] [PDF]  

Management of Treatment-Related Toxicity in Advanced Ovarian Cancer

Charles J. Dunton
The Oncologist 2002; 7(Supplement 5 ): 11-19; doi:10.1634/theoncologist.7-suppl_5-11
[Abstract] [Full Text] [PDF]  

Relapsed Ovarian Cancer: Challenges and Management Strategies for a Chronic Disease

Deborah K. Armstrong
The Oncologist 2002; 7(Supplement 5 ): 20-28; doi:10.1634/theoncologist.7-suppl_5-20
[Abstract] [Full Text] [PDF]  

Alternate Dosing Schedules for Topotecan in the Treatment of Recurrent Ovarian Cancer

Robert Morris, Adnan Munkarah
The Oncologist 2002; 7(Supplement 5 ): 29-35; doi:10.1634/theoncologist.7-suppl_5-29
[Abstract] [Full Text] [PDF]  

Update on the Treatment of Cervical and Uterine Carcinoma: Focus on Topotecan

James V. Fiorica
The Oncologist 2002; 7(Supplement 5 ): 36-45; doi:10.1634/theoncologist.7-suppl_5-36
[Abstract] [Full Text] [PDF]  

Emerging Role of Topotecan in Front-Line Treatment of Carcinoma of the Ovary

Robert L. Coleman
The Oncologist 2002; 7(Supplement 5 ): 46-55; doi:10.1634/theoncologist.7-suppl_5-46
[Abstract] [Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.